The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. The Wegovy pill is essentially a higher-dose version of Rybselsus. “The efficacy for the obesity pill at the end of the day is driven by dose. The Wegovy pill is 25 milligrams while Rybelsus is 14 milligrams. Unlike the Wegovy pill, orforglipron has no food or water restrictions.